Pathology & Oncology Research

, Volume 3, Issue 1, pp 74–77 | Cite as

Risk factors for AIDS associated kaposi’s sarcoma

An European multicentre case control study
  • Jordi Casabona
  • Gemma GambÚs
  • Marti Vall
  • Anna RodÉs
Special Report

Abstract

EURO-SHAKS, European study on HIV associated Kaposi’s sarcoma, is a BIOMED 1 project financed by the European Union (DG XII). The Spanish side of the project has been financed by FISS (Fondo de Investigaciones Sanitarias). The aims of this study are to identify possible genetic, behavioural, biological and environmental risk factors for HIV associated Kaposi’s sarcoma through a multicentre case-control study. An extensive personal questionnaire, a clinical data form and blood sample is required from all participants. In addition, a cutaneous biopsy is request from KS patients. The presence of several European groups in this project implies a large and diverse sample size and will allow to correlate the behaviour, clinical and biological data in different geographical areas, and therefore study the possible transmission routes as well as the natural history of the putative causal agent of KS. One of the main objectives of EURO-SHAKS is to create a European Bank of AIDS biological samples for possible future investigations.

Key words

AIDS Kaposi’s sarcoma risk factors case-control study 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chang Y, Cesarman E, Pessin MS, et al: Identification of Her- pesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–1869, 1994.PubMedCrossRefGoogle Scholar
  2. 2.
    Boshoff C, Whitby D, HatziioannouT, et al: Kaposi’s sarcoma associated herpesvirus in HIV-negative Kaposi’s sarcoma. Lancet, 345:1043–1044, 1995.PubMedCrossRefGoogle Scholar
  3. 3.
    Noel JC, Hermans P, AndreJ, et al: Herpesvirus-like DNA sequences and Kaposi’s sarcoma Cancer 77(10):2132–2136, 1996.Google Scholar
  4. 4.
    Beral V,Petterman TA, Berkelman RL and JaffeH: Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335:123–128, 1990.PubMedCrossRefGoogle Scholar
  5. 5.
    Beral V, Bull D, DarbyS, et al: Risk of Kaposi’s sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 339:632–635, 1992.PubMedCrossRefGoogle Scholar
  6. 6.
    Friedman-Kien AE, Laubenstein LJ, RubinsteinP, et al: Disseminated Kaposi’s sarcoma in homosexual men. Ann Intern Med 96:693–700, 1982.PubMedGoogle Scholar
  7. 8.
    Gao SJ, Kingsley L, LiM, et al: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Med, 2:925–928, 1996.PubMedCrossRefGoogle Scholar
  8. 9.
    Kedes DH, Operskalski E, BushM, et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med, 2:918–924, 1996.PubMedCrossRefGoogle Scholar
  9. 10.
    Simpson GR, Schultz TE Whitby D, et al: Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet, 349:1133–1138, 1996.CrossRefGoogle Scholar
  10. 11.
    Lennette ET, Blackbourn DJ, Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet, 348:858–861, 1996.PubMedCrossRefGoogle Scholar

Copyright information

© Arányi Lajos Foundation 1997

Authors and Affiliations

  • Jordi Casabona
    • 1
  • Gemma GambÚs
    • 1
  • Marti Vall
    • 1
  • Anna RodÉs
    • 1
  1. 1.Hopital Universitari Germans Trias i Pujol.BadalonaSpain

Personalised recommendations